Wednesday, 26 October 2016

{LONGTERMINVESTORS} News 27-10-2016



 

Securities in Ban For Trade Date 27-OCT-2016:          

1        CEATLTD

2        JINDALSTEL

3        TV18BRDCST

 


Circulars

 

Caution towards SMS tips

https://www.nseindia.com/content/circulars/INVG33495.zip

 

Suspension of trading in Everonn Education Limited

https://www.nseindia.com/content/circulars/CML33497.pdf

 


Market buzz

 

Govt to take up divestment proposals today

 

Cyrus Mistry's e-mail warns of $18 billion writedown at Tata Sons

 

Deepak Parekh: Very sad day for India Inc seeing removal of Cyrus Mistry as Chairman

 

Government may extend stock limits on sugar traders for six months

 

Sebi, exchanges seek clarification from Tata Group on Cyrus Mistry letter

 

Ratan Tata against selling Tata Steel's  UK business in whole or parts

 

Dr Reddy's announces strategic deal with Gland Pharma

 

Hero Moto approves investing 205 cr in  Ather Energy

 

Sun Pharma to Acquire Ocular Tech for $40 mn upfront

 

Iran gives ultimatum to OVL on  gas field development

 

Gulf Oil enters into a strategic OEM  tie up with Bajaj Auto

 

Lakshmi Machine Works: Board approves buyback of 3.1 lakh equity shares at a price not exceeding Rs.4,450 per share

 

Mandhana Industries: Majority banks agree to invoke strategic debt restructuring

 

HERO MOTO Q2: Net Profit At Rs 1000 Cr Vs 790 Cr

 

THOMAS COOK Q2: Consol Net Profit At Rs 20.04 Cr  Vs Net Loss Of Rs 6.83 Cr YoY

 

IIFL HOLDINGS Q2: Net Profit At Rs 180 Cr Vs Rs 140 Cr YoY

 

CUMMINS INDIA Q2: Net Profit At Rs 197 Cr Vs Rs 198 Cr YoY

 

Raymond Q2 Cons Net Profit At Rs 6.6 Cr Vs Rs 5.7 Cr (YoY)

 

Torrent Pharma Q2 Net Profit Down 59.3% At Rs207 Cr Vs Rs 509 Cr (YoY)

 

Exide Q2 Net Profit At Rs181 Cr Vs CNBC-TV18 Poll Of Rs178 Cr

 

JUST DIAL Q2 : PAT at 29.6 cr vs 38.9 cr,  down 23.9% QoQ

 

JK LAKSHMI CEM Q2:PAT at Rs 24.9 cr vs loss of Rs 8.4 cr YoY.

 

Indian HumePipe Q2:PAT 21.8 Cr Vs 7 Cr

 

Emami Paper Mills Q2 Net Profit 13.6 Cr Vs 0.4 Cr

 

Excel Crop Q2 Net Profit Up 35.5%

 


Broker's Corner

 

UBS ON TORRENT PHARMA : Maintains Neutral, target of 1,650

 

MS ON JSW ENERGY : Maintains Underweight, target of 62

 

UBS ON ITC : Maintains Buy, target of 320

 

MS ON HUL : Maintains Underweight, target of 790

 

KOTAK ON HERO : Maintains Sell, raises target to  3,000 from 2,950

 

CITI ON HERO : Maintains Sell, target of 2,920

 

IDFC ON HDFC  : Maintains Outperform, target of 1,470

 

CITI ON EXIDE : Maintains Buy, raises target to  234 from 204

 

DB ON CUMMINS : Maintains Buy, target of  1,025

 

DB ON CANARA BANK : Maintains Sell, raises target to  205 from 180

 

CLSA ON CADILA : Upgrades to Buy from Underperform, raises target to 470 from 360

 

MACQUARIE ON CADILA : Maintains Outperform; raises target  to 440 from 400



--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.

No comments:

Post a Comment